BullFrog AI Holdings Inc. (NASDAQ: BFRG) announced it has regained compliance with Nasdaq's minimum stockholders' equity requirement of $2.5 million, according to a notice received from the exchange on April 21.

The artificial intelligence company focused on biomedical data analysis achieved compliance through sales under its existing at-the-market sales facility and equity-line-of-credit facility. Nasdaq confirmed the company met the stockholders' equity requirement under listing rule 5550(b)(1).

The exchange will subject BullFrog AI to mandatory panel monitoring for one year beginning April 21. If the company falls out of compliance with the equity rule during this monitoring period, it will not receive additional time to regain compliance, though it may request a hearing with the Nasdaq Hearings Panel before potential delisting.

BullFrog AI CEO Vin Singh attributed the compliance achievement to executing business objectives in the first quarter, including a commercial agreement announced in March with what the company described as a top 5 global pharmaceutical company. Singh stated this agreement provided validation for the company's technology capabilities.

The Gaithersburg, Maryland-based company develops artificial intelligence and machine learning solutions for drug discovery and development. BullFrog AI uses its proprietary bfLEAP platform to analyze biological data with the goal of streamlining therapeutics development and reducing clinical trial failure rates.

The announcement comes as part of the company's efforts to maintain its Nasdaq listing while extending its cash runway and preserving shareholder value through what management characterized as minimally dilutive financing structures.